Ann M. Sheehy

6.7k total citations · 4 hit papers
22 papers, 5.5k citations indexed

About

Ann M. Sheehy is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Ann M. Sheehy has authored 22 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 10 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Ann M. Sheehy's work include HIV Research and Treatment (16 papers), Cytomegalovirus and herpesvirus research (9 papers) and Immune Cell Function and Interaction (8 papers). Ann M. Sheehy is often cited by papers focused on HIV Research and Treatment (16 papers), Cytomegalovirus and herpesvirus research (9 papers) and Immune Cell Function and Interaction (8 papers). Ann M. Sheehy collaborates with scholars based in United States, United Kingdom and Netherlands. Ann M. Sheehy's co-authors include Michael H. Malim, Nathan Gaddis, Jonathan Choi, Kate N. Bishop, Heather M. Craig, Rebecca K. Holmes, Michael S. Neuberger, Reuben S. Harris, Svend K. Petersen‐Mahrt and Ian N. Watt and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ann M. Sheehy

21 papers receiving 5.5k citations

Hit Papers

Isolation of a human gene that inhibits HIV-1 infection a... 2002 2026 2010 2018 2002 2003 2003 2004 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann M. Sheehy United States 16 4.0k 2.1k 1.9k 1.9k 1.9k 22 5.5k
Renate König Germany 25 2.7k 0.7× 1.5k 0.7× 1.6k 0.8× 1.3k 0.7× 1.8k 0.9× 59 4.3k
Trinity Zang United States 24 3.1k 0.8× 1.5k 0.7× 2.0k 1.1× 1.6k 0.9× 1.8k 1.0× 32 5.6k
Denise Guétard France 33 4.4k 1.1× 2.5k 1.2× 2.5k 1.3× 2.1k 1.1× 2.0k 1.0× 58 7.1k
Jean‐Pierre Vartanian France 35 2.1k 0.5× 1.3k 0.6× 1.2k 0.6× 1.5k 0.8× 2.0k 1.1× 82 5.0k
Mary F. Kearney United States 37 5.7k 1.4× 4.3k 2.0× 1.6k 0.8× 1.2k 0.6× 1.3k 0.7× 104 6.6k
Markus Thali United States 37 4.0k 1.0× 1.9k 0.9× 2.2k 1.2× 903 0.5× 1.9k 1.0× 54 5.6k
Masanori Hayami Japan 38 2.4k 0.6× 1.6k 0.7× 2.2k 1.1× 1.6k 0.8× 906 0.5× 227 5.5k
Marc Alizon France 36 4.7k 1.2× 2.4k 1.1× 2.5k 1.3× 1.6k 0.9× 1.7k 0.9× 59 6.5k
R L Willey United States 19 5.3k 1.3× 2.7k 1.3× 2.0k 1.1× 1.4k 0.7× 1.7k 0.9× 21 5.9k
Colombe Chappey United States 34 2.8k 0.7× 2.0k 0.9× 952 0.5× 798 0.4× 1.0k 0.5× 71 4.3k

Countries citing papers authored by Ann M. Sheehy

Since Specialization
Citations

This map shows the geographic impact of Ann M. Sheehy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann M. Sheehy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann M. Sheehy more than expected).

Fields of papers citing papers by Ann M. Sheehy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann M. Sheehy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann M. Sheehy. The network helps show where Ann M. Sheehy may publish in the future.

Co-authorship network of co-authors of Ann M. Sheehy

This figure shows the co-authorship network connecting the top 25 collaborators of Ann M. Sheehy. A scholar is included among the top collaborators of Ann M. Sheehy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann M. Sheehy. Ann M. Sheehy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chaudoir, Stephenie R., et al.. (2018). The effectiveness of the Bringing in the Bystander™ program among first-year students at a religiously-affiliated liberal arts college. Journal of Social and Political Psychology. 6(2). 511–525. 9 indexed citations
3.
Sheehy, Ann M., Vikas Misra, Marie K. Mankowski, et al.. (2015). Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1. Virology. 484. 276–287. 13 indexed citations
4.
Sheehy, Ann M., Andrew J. Brazier, Vikas Misra, et al.. (2015). Identification of a Novel HIV-1 Inhibitor Targeting Vif-dependent Degradation of Human APOBEC3G Protein. Journal of Biological Chemistry. 290(16). 10504–10517. 35 indexed citations
5.
Prestwich, Kenneth N. & Ann M. Sheehy. (2015). Integrating Concepts in Biology: A Model for More Effective Ways to Introduce Students to Biology. CBE—Life Sciences Education. 14(3). fe3–fe3. 3 indexed citations
6.
Farrow, Melissa A., Eun‐Young Kim, Steven M. Wolinsky, & Ann M. Sheehy. (2010). NFAT and IRF Proteins Regulate Transcription of the Anti-HIV Gene, APOBEC3G. Journal of Biological Chemistry. 286(4). 2567–2577. 23 indexed citations
7.
Farrow, Melissa A. & Ann M. Sheehy. (2008). Vif and Apobec3G in the Innate Immune Response to HIV: a Tale of Two Proteins. Future Microbiology. 3(2). 145–154. 10 indexed citations
8.
Holmes, Rebecca K., Heather M. Craig, Kevin Klein, et al.. (2005). Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity. Current Biology. 15(2). 166–170. 410 indexed citations
9.
Gaddis, Nathan, Ann M. Sheehy, Chad M. Swanson, et al.. (2004). Further Investigation of Simian Immunodeficiency Virus Vif Function in Human Cells. Journal of Virology. 78(21). 12041–12046. 58 indexed citations
10.
Harris, Reuben S., Kate N. Bishop, Ann M. Sheehy, et al.. (2004). DNA Deamination Mediates Innate Immunity to Retroviral Infection. Cell. 116(4). 629–629. 84 indexed citations
11.
Bishop, Kate N., Rebecca K. Holmes, Ann M. Sheehy, et al.. (2004). Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins. Current Biology. 14(15). 1392–1396. 522 indexed citations breakdown →
12.
Bishop, Kate N., Ann M. Sheehy, Heather M. Craig, et al.. (2004). DNA deamination mediates innate immunity to retroviral infection (vol 113, pg 803, 2003). Research Portal (King's College London). 116(4). 20 indexed citations
13.
Harris, Reuben S., Kate N. Bishop, Ann M. Sheehy, et al.. (2003). DNA Deamination Mediates Innate Immunity to Retroviral Infection. Cell. 113(6). 803–809. 1083 indexed citations breakdown →
14.
Sheehy, Ann M., Nathan Gaddis, & Michael H. Malim. (2003). The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nature Medicine. 9(11). 1404–1407. 787 indexed citations breakdown →
15.
Harris, Reuben S., Ann M. Sheehy, Heather M. Craig, Michael H. Malim, & Michael S. Neuberger. (2003). DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nature Immunology. 4(7). 641–643. 67 indexed citations
16.
Gaddis, Nathan, Elena Chertova, Ann M. Sheehy, Louis E. Henderson, & Michael H. Malim. (2003). Comprehensive Investigation of the Molecular Defect in vif -Deficient Human Immunodeficiency Virus Type 1 Virions. Journal of Virology. 77(10). 5810–5820. 58 indexed citations
17.
Sheehy, Ann M., Nathan Gaddis, Jonathan Choi, & Michael H. Malim. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 418(6898). 646–650. 1875 indexed citations breakdown →
18.
Sheehy, Ann M. & Mark S. Schlissel. (1999). Overexpression of RelA Causes G1 Arrest and Apoptosis in a Pro-B Cell Line. Journal of Biological Chemistry. 274(13). 8708–8716. 45 indexed citations
19.
Simon, James H. M., et al.. (1999). Mutational Analysis of the Human Immunodeficiency Virus Type 1 Vif Protein. Journal of Virology. 73(4). 2675–2681. 56 indexed citations
20.
Bain, Gretchen, Hein P. J. te Riele, Ann J. Feeney, et al.. (1997). Both E12 and E47 Allow Commitment to the B Cell Lineage. Immunity. 6(2). 145–154. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026